The GSTM1 null genotype was present in 35% of control cases and 34% of the CML patients, (OR=0.975, 95%CI: 0.58-1.58;p-value=0.863). Here, GSTM1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.